Sodium And Chloride Dependent Glycine Transporter 1 (Glyt1 or Solute Carrier Family 6 Member 9 or SLC6A9) - Pipeline Review, H2 2018

Publisher Name :
Date: 10-Jul-2018
No. of pages: 36

Sodium And Chloride Dependent Glycine Transporter 1 (Glyt1 or Solute Carrier Family 6 Member 9 or SLC6A9) - Pipeline Review, H2 2018

Summary

According to the recently published report 'Sodium And Chloride Dependent Glycine Transporter 1 - Pipeline Review, H2 2018'; Sodium And Chloride Dependent Glycine Transporter 1 (Glyt1 or Solute Carrier Family 6 Member 9 or SLC6A9) pipeline Target constitutes close to 7 molecules. Out of which approximately 5 molecules are developed by companies and remaining by the universities/institutes.

Sodium And Chloride Dependent Glycine Transporter 1 (Glyt1 or Solute Carrier Family 6 Member 9 or SLC6A9) - Sodium- and chloride-dependent glycine transporter 1 is a protein encoded by the SLC6A9 gene. It terminates the action of glycine by its high affinity sodium-dependent reuptake into presynaptic terminals. It plays a role in regulation of glycine levels in NMDA receptor-mediated neurotransmission.

The report 'Sodium And Chloride Dependent Glycine Transporter 1 - Pipeline Review, H2 2018' outlays comprehensive information on the Sodium And Chloride Dependent Glycine Transporter 1 (Glyt1 or Solute Carrier Family 6 Member 9 or SLC6A9) targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type; that are being developed by Companies / Universities.

It also reviews key players involved in Sodium And Chloride Dependent Glycine Transporter 1 (Glyt1 or Solute Carrier Family 6 Member 9 or SLC6A9) targeted therapeutics development with respective active and dormant or discontinued projects. Currently, The molecules developed by companies in Phase II and Preclinical stages are 3 and 2 respectively. Similarly, the universities portfolio in Preclinical stages comprises 2 molecules, respectively.

Report covers products from therapy areas Central Nervous System, Hematological Disorders and Metabolic Disorders which include indications Cognitive Impairment Associated With Schizophrenia (CIAS), Schizophrenia, Alzheimer's Disease, Bipolar Disorder (Manic Depression), Cognitive Impairment, Memory Impairment, Parkinson's Disease, Pervasive Developmental Disorder (PDD) and Thalassemia.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope

- The report provides a snapshot of the global therapeutic landscape for Sodium And Chloride Dependent Glycine Transporter 1 (Glyt1 or Solute Carrier Family 6 Member 9 or SLC6A9)

- The report reviews Sodium And Chloride Dependent Glycine Transporter 1 (Glyt1 or Solute Carrier Family 6 Member 9 or SLC6A9) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources

- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages

- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities

- The report reviews key players involved in Sodium And Chloride Dependent Glycine Transporter 1 (Glyt1 or Solute Carrier Family 6 Member 9 or SLC6A9) targeted therapeutics and enlists all their major and minor projects

- The report assesses Sodium And Chloride Dependent Glycine Transporter 1 (Glyt1 or Solute Carrier Family 6 Member 9 or SLC6A9) targeted therapeutics based on mechanism of action (MoA), route of administration (RoA) and molecule type

- The report summarizes all the dormant and discontinued pipeline projects

- The report reviews latest news and deals related to Sodium And Chloride Dependent Glycine Transporter 1 (Glyt1 or Solute Carrier Family 6 Member 9 or SLC6A9) targeted therapeutics

Reasons to buy

- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Identify and understand the targeted therapy areas and indications for Sodium And Chloride Dependent Glycine Transporter 1 (Glyt1 or Solute Carrier Family 6 Member 9 or SLC6A9)

- Identify the use of drugs for target identification and drug repurposing

- Identify potential new clients or partners in the target demographic

- Develop strategic initiatives by understanding the focus areas of leading companies

- Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics

- Devise corrective measures for pipeline projects by understanding Sodium And Chloride Dependent Glycine Transporter 1 (Glyt1 or Solute Carrier Family 6 Member 9 or SLC6A9) development landscape

- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Sodium And Chloride Dependent Glycine Transporter 1 (Glyt1 or Solute Carrier Family 6 Member 9 or SLC6A9) - Pipeline Review, H2 2018

Table of Contents
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Sodium And Chloride Dependent Glycine Transporter 1 (Glyt1 or Solute Carrier Family 6 Member 9 or SLC6A9) - Overview
Sodium And Chloride Dependent Glycine Transporter 1 (Glyt1 or Solute Carrier Family 6 Member 9 or SLC6A9) - Therapeutics Development
Products under Development by Stage of Development
Products under Development by Therapy Area
Products under Development by Indication
Products under Development by Companies
Products under Development by Universities/Institutes
Sodium And Chloride Dependent Glycine Transporter 1 (Glyt1 or Solute Carrier Family 6 Member 9 or SLC6A9) - Therapeutics Assessment
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Sodium And Chloride Dependent Glycine Transporter 1 (Glyt1 or Solute Carrier Family 6 Member 9 or SLC6A9) - Companies Involved in Therapeutics Development
Boehringer Ingelheim GmbH
F. Hoffmann-La Roche Ltd
Pfizer Inc
Sodium And Chloride Dependent Glycine Transporter 1 (Glyt1 or Solute Carrier Family 6 Member 9 or SLC6A9) - Drug Profiles
BI-425809 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
bitopertin - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
DNS-006 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
PF-03463275 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
PGW-5 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecule to Inhibit GlyT1 for Parkinson's Disease and Schizophrenia - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
VU-0410120 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Sodium And Chloride Dependent Glycine Transporter 1 (Glyt1 or Solute Carrier Family 6 Member 9 or SLC6A9) - Dormant Products
Sodium And Chloride Dependent Glycine Transporter 1 (Glyt1 or Solute Carrier Family 6 Member 9 or SLC6A9) - Discontinued Products
Sodium and Chloride Dependent Glycine Transporter 1 (Glyt1 or Solute Carrier Family 6 Member 9 or SLC6A9) - Product Development Milestones
Featured News & Press Releases
Jan 21, 2014: Roche provides update on the first two of six phase III studies of bitopertin in schizophrenia
Dec 06, 2010: Phase II Study with First-In-Class Investigational Drug Demonstrates Improvement In Negative Symptoms In Patients With Schizophrenia
Dec 06, 2010: Roche Announces Eight-Week Results From Phase II Study Of RG16781 In Patients With Schizophrenia
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Number of Products under Development by Stage of Development, H2 2018
Number of Products under Development by Therapy Areas, H2 2018
Number of Products under Development by Indication, H2 2018
Number of Products under Development by Companies, H2 2018
Products under Development by Companies, H2 2018
Number of Products under Investigation by Universities/Institutes, H2 2018
Products under Investigation by Universities/Institutes, H2 2018
Number of Products by Stage and Mechanism of Actions, H2 2018
Number of Products by Stage and Route of Administration, H2 2018
Number of Products by Stage and Molecule Type, H2 2018
Pipeline by Boehringer Ingelheim GmbH, H2 2018
Pipeline by F. Hoffmann-La Roche Ltd, H2 2018
Pipeline by Pfizer Inc, H2 2018
Dormant Products, H2 2018
Discontinued Products, H2 2018

List of Figures
Number of Products under Development by Stage of Development, H2 2018
Number of Products under Development by Therapy Areas, H2 2018
Number of Products under Development by Top 10 Indications, H2 2018
Number of Products by Stage and Mechanism of Actions, H2 2018
Number of Products by Stage and Molecule Type, H2 2018
  • Global and Chinese Thermostable Phytase Enzyme Industry, 2018 Market Research Report
    Published: 22-Nov-2018        Price: US 3000 Onwards        Pages: 149
    The 'Global and Chinese Thermostable Phytase Enzyme Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Thermostable Phytase Enzyme industry with a focus on the Chinese market. The report provides key statistics on the market status of the Thermostable Phytase Enzyme manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Firstly, the report provides a basic overview......
  • Global and Chinese Sheep Placenta Extract Industry, 2018 Market Research Report
    Published: 22-Nov-2018        Price: US 3000 Onwards        Pages: 147
    The 'Global and Chinese Sheep Placenta Extract Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Sheep Placenta Extract industry with a focus on the Chinese market. The report provides key statistics on the market status of the Sheep Placenta Extract manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Firstly, the report provides a basic overview of the industr......
  • Global and Chinese Fluvoxamine Industry, 2018 Market Research Report
    Published: 22-Nov-2018        Price: US 3000 Onwards        Pages: 147
    The 'Global and Chinese Fluvoxamine Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Fluvoxamine industry with a focus on the Chinese market. The report provides key statistics on the market status of the Fluvoxamine manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Firstly, the report provides a basic overview of the industry including its definition, appli......
  • Global and Chinese Transthyretin Industry, 2018 Market Research Report
    Published: 22-Nov-2018        Price: US 3000 Onwards        Pages: 140
    The 'Global and Chinese Transthyretin Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Transthyretin industry with a focus on the Chinese market. The report provides key statistics on the market status of the Transthyretin manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Firstly, the report provides a basic overview of the industry including its definition,......
  • Global and Chinese Cyclin Dependent Kinase 1 Industry, 2018 Market Research Report
    Published: 22-Nov-2018        Price: US 3000 Onwards        Pages: 139
    The 'Global and Chinese Cyclin Dependent Kinase 1 Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Cyclin Dependent Kinase 1 industry with a focus on the Chinese market. The report provides key statistics on the market status of the Cyclin Dependent Kinase 1 manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Firstly, the report provides a basic overview of th......
  • Global and Chinese Voglibose Industry, 2018 Market Research Report
    Published: 22-Nov-2018        Price: US 3000 Onwards        Pages: 142
    The 'Global and Chinese Voglibose Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Voglibose industry with a focus on the Chinese market. The report provides key statistics on the market status of the Voglibose manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Firstly, the report provides a basic overview of the industry including its definition, application......
  • Global and Chinese Epstein-Barr Virus (HHV-4) Infections Treatment Industry, 2018 Market Research Report
    Published: 22-Nov-2018        Price: US 3000 Onwards        Pages: 137
    The 'Global and Chinese Epstein-Barr Virus (HHV-4) Infections Treatment Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Epstein-Barr Virus (HHV-4) Infections Treatment industry with a focus on the Chinese market. The report provides key statistics on the market status of the Epstein-Barr Virus (HHV-4) Infections Treatment manufacturers and is a valuable source of guidance and direction for companies and individuals interested in......
  • Global and Chinese Medical Hair Replacemen Industry, 2018 Market Research Report
    Published: 22-Nov-2018        Price: US 3000 Onwards        Pages: 142
    The 'Global and Chinese Medical Hair Replacemen Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Medical Hair Replacemen industry with a focus on the Chinese market. The report provides key statistics on the market status of the Medical Hair Replacemen manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Firstly, the report provides a basic overview of the indu......
  • Global and Chinese Rotavirus Infections Drug Industry, 2018 Market Research Report
    Published: 22-Nov-2018        Price: US 3000 Onwards        Pages: 144
    The 'Global and Chinese Rotavirus Infections Drug Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Rotavirus Infections Drug industry with a focus on the Chinese market. The report provides key statistics on the market status of the Rotavirus Infections Drug manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Firstly, the report provides a basic overview of th......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs